Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAlkemy Capital. Regulatory News (ALK)

Share Price Information for Alkemy Capital. (ALK)

Share Price is delayed by 15 minutes
Get Live Data
234.00    -12.50 (-4.91%)
Bid:
236.00
Ask:
248.00
Spread: 12.00 (5.085%)
Market Cap: £25.69m
ALK Live PriceLast checked at - London Stock Exchange

Intraday Alkemy Capital. Share Chart

Loan Conversion

29 Jan 2026 16:07

RNS Number : 9791Q
Alkemy Capital Investments PLC
29 January 2026
 

29 January 2026

 

Alkemy Capital Investments Plc

Loan Conversion

 

Alkemy Capital Investments Plc ("Alkemy" or the "Company") (LSE: ALK) (JV2:FRA) has received a loan conversion notice from the debt facility provider, as set out in the RNS dated 31 July 2025, pursuant to which £236,363.64 of principal and £8,943.96 of interest is being converted at £3.48, resulting in the issue of 70,446 ordinary shares of 2 pence each in the Company ("Ordinary Shares").

The Company will accordingly issue 70,446 new Ordinary Shares in the Company (the "New Ordinary Shares").

The Company also announces that it has issued 46,749 warrants at an exercise price of £4.01 for a 48 month period.

 

Admission

Application will be made for the New Ordinary Shares to be admitted to trading on the Equity Shares (transition) category of the Official List and the Main Market of the London Stock Exchange at 8.00 a.m. on 4 February 2026 ("Admission").

Total Voting Rights

The Company hereby notifies the market, in accordance with the FCA's Disclosure Guidance and Transparency Rules, that on Admission, the Company's enlarged share capital will consist of 10,733,038 Ordinary Shares. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

Further information

 

For further information, please visit Alkemy's website: www.alkemycapital.co.uk or TVL's website www.teesvalleylithium.co.uk.

-Ends-

Alkemy Capital Investments Plc

 

Tel: 0207 317 0636

info@alkemycapital.co.uk

Zeus Capital

Tel: 0203 829 5000

 

ABOUT US

 

Alkemy Capital Investments plc: Alkemy is focused on the development of critical mineral infrastructure to support the global energy transition. Through its wholly owned subsidiary, TVL, Alkemy is leading the way in establishing Europe's first independent lithium hydroxide refinery.

 

Tees Valley Lithium Limited: TVL is committed to supplying battery-grade lithium chemicals to meet the growing demand of the electric vehicle supply chain in Europe. Strategically located at in Teesside, UK, TVL is developing a low-carbon, independent lithium supply chain for European battery manufacturers.

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCQKLFLQFLBBBE
Date   Source Headline
2nd May 201212:39 pmRNSDirector/PDMR Shareholding
30th Apr 201210:22 amRNSNotice of AGM
27th Apr 20127:00 amRNSCompletion of Acquisition of Greenpark Energy Ltd
25th Apr 20129:40 amRNSBiogas and North East Wales AD Project Update
25th Apr 20127:00 amRNSre Update on Projects
7th Mar 20127:00 amRNSPreliminary Results
2nd Feb 20127:00 amRNSAcquisition and Trading Update
22nd Dec 20117:00 amRNSAppointment of Broker
20th Sep 20117:00 amRNSNew banking facility
15th Sep 20114:36 pmRNSDirector/PDMR Shareholding - Replacement
15th Sep 20112:44 pmRNSHolding(s) in Company
7th Sep 20117:00 amRNSInterim Results
31st Aug 20119:00 amRNSALKANE & TEG AWARDED BIDDER STATUS FOR AD PLANT
11th Aug 20119:00 amRNSNotice of Results
15th Jul 20114:00 pmRNSAdditional Listing
10th Jun 20117:00 amRNSDECC Licence Approval for Seven Star Acquisition
27th May 20115:19 pmRNSHolding(s) in Company
27th May 201111:27 amRNSTotal Voting Rights
26th May 201110:58 amRNSDirector/PDMR Shareholding
26th May 201110:35 amRNSAcquisition and Fundraising
13th May 201111:54 amRNSHolding(s) in Company
4th May 20112:24 pmRNSResults of AGM
4th May 20117:00 amRNSAGM Statement and Trading Update
12th Apr 201111:06 amRNSAnnual Financial Report
6th Apr 20113:51 pmRNSDirector/PDMR Shareholding
9th Mar 20117:00 amRNSPreliminary Results
11th Jan 20117:00 amRNSNotice of Results and Trading Update
11th Nov 201011:48 amRNSHolding(s) in Company
20th Oct 20103:27 pmRNSAdditional Listing
20th Oct 20103:27 pmRNSAdditional Listing
8th Oct 20101:50 pmRNSDirector/PDMR Shareholding
8th Oct 20101:48 pmRNSAdditional Listing
30th Sep 201012:02 pmRNSAdditional Listing
30th Sep 201012:01 pmRNSAdditional Listing
30th Sep 201012:00 pmRNSTotal Voting Rights
16th Sep 201012:18 pmRNSAdditional Listing
8th Sep 20107:00 amRNSInterim Results
3rd Sep 20107:00 amRNSAlkane Extends Tolling Agreement with GDF SUEZ
24th Aug 201010:16 amRNSNotice of Results
7th Jul 20107:00 amRNSTrading Statement
6th May 20107:00 amRNSGrant of Options
28th Apr 20102:28 pmRNSResult of AGM
28th Apr 20107:00 amRNSTrading Statement
13th Apr 20103:06 pmRNSAnnual Report and Accounts
11th Mar 201011:50 amRNSDirector/PDMR Shareholding
10th Mar 20107:00 amRNSPreliminary Results
1st Mar 201010:49 amRNSAdditional Listing
21st Dec 20097:00 amRNSTrading Update Apointment of NED & Collaboration
2nd Nov 20097:00 amRNSAlkane Signs Tolling Contract with GDF SUEZ
16th Sep 20097:00 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.